Rhythm Pharmaceuticals (RYTM) Change in Inventory (2022 - 2026)

Rhythm Pharmaceuticals (RYTM) has 5 years of Change in Inventory data on file, last reported at $3.1 million in Q1 2026.

• Change in Inventory for Q1 2026 came in at $3.1 million, up 436.7% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.0 million (down 7.62% YoY), and the FY2025 annual result was $7.5 million, down 26.12% from the prior year.
• Change in Inventory eased to $3.1 million in Q1 2026 per RYTM's latest filing, from $4.9 million in the prior quarter.
• Over five years, Change in Inventory peaked at $4.9 million in Q4 2025 and troughed at -$479000.0 in Q2 2025.
• A 5-year average of $1.8 million and a median of $1.6 million in 2023 frame the typical range for Change in Inventory.
• The sharpest annual moves came in 2023 and 2025: Change in Inventory soared 31800.0% in 2023, then sank 113.74% in 2025.
• A 5-year view of Change in Inventory shows it stood at $1.2 million in 2022, then slipped by 29.98% to $862000.0 in 2023, then surged by 462.18% to $4.8 million in 2024, then rose by 1.67% to $4.9 million in 2025, then plunged by 37.37% to $3.1 million in 2026.
• Business Quant data shows RYTM's Change in Inventory at $3.1 million in Q1 2026, $4.9 million in Q4 2025, and $2.5 million in Q3 2025.